|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/18 | |
| A61K 39/00 | |||
| A61K 39/395 | |||
| C07K 16/22 |
| (11) | Number of the document | 2688910 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12711543.4 |
| Date of filing the European patent application | 2012-03-23 | |
| (97) | Date of publication of the European application | 2014-01-29 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/030364 |
| Date | 2012-03-23 |
| (87) | Number | WO 2012/135035 |
| Date | 2012-10-04 |
| (30) | Number | Date | Country code |
| 201161467868 P | 2011-03-25 | US |
| (72) |
CLOGSTON, Christi, L., US
CHRISTIAN, Twinkle, R., US
OSSLUND, Timothy, D., US
FREEMAN, Elisabeth, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (54) | ANTI-SCLEROSTIN ANTIBODY CRYSTALS AND FORMULATIONS THEREOF |
| ANTI-SCLEROSTIN ANTIBODY CRYSTALS AND FORMULATIONS THEREOF |